A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development

Nadia Giarratana, Giuseppe Penna, Susana Amuchastegui, Roberto Mariani, Kenn C. Daniel, Luciano Adorini

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Type 1 diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration into the pancreatic islets, and we have previously shown that treatment of adult NOD mice with a vitamin D analog arrests the progression of insulitis, blocks Th1 cell infiltration into the pancreas, and markedly reduces T1D development, suggesting inhibition of chemokine production by islet cells. In this study, we show that all TLRs are expressed by mouse and human islet cells, and their engagement by pathogen-derived ligands markedly enhances proinflammatory chemokine production. The vitamin D analog significantly down-regulates in vitro and in vivo proinflammatory chemokine production by islet cells, inhibiting T cell recruitment into the pancreatic islets and T1D development. The inhibition of islet chemokine production in vivo persists after restimulation with TLR ligands and is associated with up-regulation of IκBα transcription, an inhibitor of NF-κB and with arrest of NF-κBp65 nuclear translocation, highlighting a novel mechanism of action exerted by vitamin D receptor ligands potentially relevant for the treatment of T1D and other autoimmune diseases.

Original languageEnglish
Pages (from-to)2280-2287
Number of pages8
JournalJournal of Immunology
Volume173
Issue number4
Publication statusPublished - Aug 15 2004

Fingerprint

Type 1 Diabetes Mellitus
Islets of Langerhans
Chemokines
Vitamin D
Down-Regulation
T-Lymphocytes
Ligands
Autoimmune Diseases
Inbred NOD Mouse
Th1 Cells
Calcitriol Receptors
Pancreas
Leukocytes
Up-Regulation

ASJC Scopus subject areas

  • Immunology

Cite this

Giarratana, N., Penna, G., Amuchastegui, S., Mariani, R., Daniel, K. C., & Adorini, L. (2004). A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. Journal of Immunology, 173(4), 2280-2287.

A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. / Giarratana, Nadia; Penna, Giuseppe; Amuchastegui, Susana; Mariani, Roberto; Daniel, Kenn C.; Adorini, Luciano.

In: Journal of Immunology, Vol. 173, No. 4, 15.08.2004, p. 2280-2287.

Research output: Contribution to journalArticle

Giarratana, N, Penna, G, Amuchastegui, S, Mariani, R, Daniel, KC & Adorini, L 2004, 'A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development', Journal of Immunology, vol. 173, no. 4, pp. 2280-2287.
Giarratana, Nadia ; Penna, Giuseppe ; Amuchastegui, Susana ; Mariani, Roberto ; Daniel, Kenn C. ; Adorini, Luciano. / A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. In: Journal of Immunology. 2004 ; Vol. 173, No. 4. pp. 2280-2287.
@article{37afaa51257c4e00b294487c468862e1,
title = "A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development",
abstract = "Type 1 diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration into the pancreatic islets, and we have previously shown that treatment of adult NOD mice with a vitamin D analog arrests the progression of insulitis, blocks Th1 cell infiltration into the pancreas, and markedly reduces T1D development, suggesting inhibition of chemokine production by islet cells. In this study, we show that all TLRs are expressed by mouse and human islet cells, and their engagement by pathogen-derived ligands markedly enhances proinflammatory chemokine production. The vitamin D analog significantly down-regulates in vitro and in vivo proinflammatory chemokine production by islet cells, inhibiting T cell recruitment into the pancreatic islets and T1D development. The inhibition of islet chemokine production in vivo persists after restimulation with TLR ligands and is associated with up-regulation of IκBα transcription, an inhibitor of NF-κB and with arrest of NF-κBp65 nuclear translocation, highlighting a novel mechanism of action exerted by vitamin D receptor ligands potentially relevant for the treatment of T1D and other autoimmune diseases.",
author = "Nadia Giarratana and Giuseppe Penna and Susana Amuchastegui and Roberto Mariani and Daniel, {Kenn C.} and Luciano Adorini",
year = "2004",
month = "8",
day = "15",
language = "English",
volume = "173",
pages = "2280--2287",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development

AU - Giarratana, Nadia

AU - Penna, Giuseppe

AU - Amuchastegui, Susana

AU - Mariani, Roberto

AU - Daniel, Kenn C.

AU - Adorini, Luciano

PY - 2004/8/15

Y1 - 2004/8/15

N2 - Type 1 diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration into the pancreatic islets, and we have previously shown that treatment of adult NOD mice with a vitamin D analog arrests the progression of insulitis, blocks Th1 cell infiltration into the pancreas, and markedly reduces T1D development, suggesting inhibition of chemokine production by islet cells. In this study, we show that all TLRs are expressed by mouse and human islet cells, and their engagement by pathogen-derived ligands markedly enhances proinflammatory chemokine production. The vitamin D analog significantly down-regulates in vitro and in vivo proinflammatory chemokine production by islet cells, inhibiting T cell recruitment into the pancreatic islets and T1D development. The inhibition of islet chemokine production in vivo persists after restimulation with TLR ligands and is associated with up-regulation of IκBα transcription, an inhibitor of NF-κB and with arrest of NF-κBp65 nuclear translocation, highlighting a novel mechanism of action exerted by vitamin D receptor ligands potentially relevant for the treatment of T1D and other autoimmune diseases.

AB - Type 1 diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration into the pancreatic islets, and we have previously shown that treatment of adult NOD mice with a vitamin D analog arrests the progression of insulitis, blocks Th1 cell infiltration into the pancreas, and markedly reduces T1D development, suggesting inhibition of chemokine production by islet cells. In this study, we show that all TLRs are expressed by mouse and human islet cells, and their engagement by pathogen-derived ligands markedly enhances proinflammatory chemokine production. The vitamin D analog significantly down-regulates in vitro and in vivo proinflammatory chemokine production by islet cells, inhibiting T cell recruitment into the pancreatic islets and T1D development. The inhibition of islet chemokine production in vivo persists after restimulation with TLR ligands and is associated with up-regulation of IκBα transcription, an inhibitor of NF-κB and with arrest of NF-κBp65 nuclear translocation, highlighting a novel mechanism of action exerted by vitamin D receptor ligands potentially relevant for the treatment of T1D and other autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=4043060025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043060025&partnerID=8YFLogxK

M3 - Article

C2 - 15294940

AN - SCOPUS:4043060025

VL - 173

SP - 2280

EP - 2287

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -